Association of polymorphic markers of the <i>XRCC1</i>, <i>ERCC5</i>, <i>TP53</i>, <i>CDKN1A1</i> genes with the survival of patients after platinum-based chemotherapy for triple negative breast cancer
Background. Breast cancer is the most common cancer among women. Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, in which there are no special targets for therapy. Therefore chemotherapy is still leading treatment for TNBC including the regiments with platinum d...
Saved in:
Main Authors: | T. M. Zavarykina (Author), P. K. Lomskova (Author), M. A. Kapralova (Author), O. O. Gordeeva (Author), I. P. Ganshina (Author), D. S. Khodyrev (Author), S. V. Khokhlova (Author), I. V. Kolyadina (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
<i>ERCC1</i> and <i>ERCC2</i> Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer
by: Andrés Barba, et al.
Published: (2024) -
ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer
by: Vaezi A, et al.
Published: (2011) -
An interplay between genes <i>SLCO1B1</i>, <i>NR2F2</i>, <i>JMJD1C</i> and obesity in developing breast cancer
by: K. N. Pasenov, et al.
Published: (2024) -
The Evaluation of <i>FGFR1</i>, <i>FGFR2</i> and <i>FOXO1</i> in Orofacial Cleft Tissue
by: Jana Goida, et al.
Published: (2022) -
Genetic Variation in <i>CYP2D6</i>, <i>UGT1A4</i>, <i>SLC6A2</i> and <i>SLCO1B1</i> Alters the Pharmacokinetics and Safety of Mirabegron
by: Paula Soria-Chacartegui, et al.
Published: (2024)